TBPH - Theravance Biopharma, Inc.
IEX Last Trade
9.83
-0.045 -0.458%
Share volume: 2,671
Last Updated: Thu 26 Dec 2024 08:29:41 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
1.30%
PREVIOUS CLOSE
CHG
CHG%
$9.88
-0.05
-0.46%
Summary score
23%
Profitability
15%
Dept financing
17%
Liquidity
75%
Performance
20%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
19.43%
Return on assets
-6.11%
Return on sales
-245.77%
Return on invested capital
168.33%
Total debt ratio
115.62%
Debt ratio change over timeo
-7.3%
Current Ratio
5.62%
Quick Ratio
5.68%
Cash Position Ratio
4.48%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-4.73%
Return on assets
-2.53%
Return on sales
-69.35%
Return on invested capital
-4.93%
Total debt ratio
41.71%
Debt ratio change over timeo
-8.59%
Current Ratio
6.33%
Quick Ratio
6.33%
Cash Position Ratio
5.21%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
-5.69%
Return on assets
-3.02%
Return on sales
-77.27%
Return on invested capital
-5.18%
Total debt ratio
44.83%
Debt ratio change over time
-12.78%
Current Ratio
5.74%
Quick Ratio
5.74%
Cash Position Ratio
4.62%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-345.66%
Return on assets
-72.7%
Return on sales
1094.99%
Return on invested capital
-1185.76%
Total debt ratio
-729.84%
Debt ratio change over time
-7.3%
Current Ratio
-57.45%
Quick Ratio
-61.32%
Cash Position Ratio
-48.63%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | TBPH | LLY | NVO | JNJ |
|---|---|---|---|---|
| Return on equity | 19.43% | 18.83% | 17.34% | 7.6% |
| Return on assets | -6.11% | 4.16% | 8.21% | 3.22% |
| Return on sales | -245.77% | 28.21% | 41.18% | 25.37% |
| Return on invested capital | 168.33% | 9.79% | -219.55% | 7.46% |
| Profitability | 50% | 55% | 72% | 36% |
| Total debt ratio | 115.62% | 82.89% | 55.88% | 60.02% |
| Debt ratio change over time | -7.3% | -4.38% | -0.73% | -33.74% |
| Dept financing | 25% | 18% | 37% | 13% |
| Current Ratio | 6.33% | 1.12% | 0% | 1.16% |
| Quick Ratio | 6.33% | 0.86% | 0% | 0.92% |
| Cash Position Ratio | 5.21% | 0.13% | 0% | 0.52% |
| Liquididy | 75% | 11% | 11% | 14% |
| Short-term ratios | TBPH | LLY | NVO | JNJ |
|---|---|---|---|---|
| Return on equity | -4.73% | 13.31% | 0% | 13.48% |
| Return on assets | -2.53% | 4.72% | 0% | 3.05% |
| Return on sales | -69.35% | 31.4% | 0% | 25.56% |
| Return on invested capital | -4.93% | 10.68% | 0% | 13.96% |
| Profitability | 0% | 94% | 0% | 87% |
| Total debt ratio | 41.71% | 80.89% | 0% | 59.04% |
| Debt ratio change over time | -8.59% | -41.82% | 0% | 7.13% |
| Dept financing | 13% | 25% | 0% | 43% |
| Current Ratio | 6.33% | 1.12% | 0% | 1.16% |
| Quick Ratio | 6.33% | 0.86% | 0% | 0.92% |
| Cash Position Ratio | 5.21% | 0.13% | 0% | 0.52% |
| Liquididy | 75% | 8% | 0% | 11% |